←
Scott C Woller MD350 posts
Scott C Woller MD avatar

Scott C Woller MD

@SCWollerMD

Physician, Intermountain Healthcare Professor of Medicine, University of Utah School of Medicine, Governor, UT Chapter ACP, Tweets my own.

◷ Joined November 2019▧ 13 Photos and videos
Bloodman avatar
⟳ Scott C Woller MD retweeted
Bloodman@Bloodman·20 Apr 2025

Great article modeling how screening for iron deficiency is cost effective! onlinelibrary.wiley.com/doi/…

Benjamin Horne 🇺🇸 avatar
⟳ Scott C Woller MD retweeted
Benjamin Horne 🇺🇸@DrBenjaminHorne·14 Oct 2024

Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent venous thromboembolism @SCWollerMD @RPTHjournal rpthjournal.org/article/S247…

ISTH avatar
⟳ Scott C Woller MD retweeted
ISTH@isth·19 Sep 2024

We have over 180 registrants so far! Help us reach 200 by the end of the day to spread awareness for #WTDay24!

📣Register now for early access on Sept 24 to join the WTD Global Roundtable. All pre-registered participants will receive exclusive benefits, including: 📌Early access to the event recording 📌An exclusive handbook on women and thrombosis for healthcare professionals This event, co-hosted by the @isth & @CDCgov, explores the intersection of women's health and thrombosis: bit.ly/3Az08kZ

Post attachment
Alex Spyropoulos avatar
⟳ Scott C Woller MD retweeted
Alex Spyropoulos@AlexSpyropoul·16 Sep 2024

Important New Report: Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Emboli… pubmed.ncbi.nlm.nih.gov/3926… @PERTConsortium @NATFthrombosis @AnticoagForum @ThrombosisCan @ThrombosisUK @canvector @TromboseLeiden @EuropeanTHA

Geoff Barnes avatar
⟳ Scott C Woller MD retweeted
Geoff Barnes@GBarnesMD·26 Jun 2023

What is the risk of #VTE recurrence for patients presenting with distal #DVT? It’s low, but meaningful over 5-10 years. Strength of index provoking risk factor was a strong predictor of recurrence. approx 2/3red we’re proximal DVT or PE. #ISTH2023

Post attachmentPost attachmentPost attachment
Vasculearn Network avatar
⟳ Scott C Woller MD retweeted
Vasculearn Network@Vasculearn·26 Jun 2023

🚨Paul Dobesh presenting some compelling data for use of Andexanet Alpha at #ISTH2023 Retrospective review comparing 4F-PCC (mean dose 2510units) to Andexanet (~2/3 low dose) 🌟Use if Andexanet Alpha led to a 50% decrease in in-house mortality. (1/3)

Post attachmentPost attachmentPost attachment